For the first time, European Society of Cardiology (ESC) guidelines have aggregated in 1
single document recommendations for the management of patients with non-ST-segment …

Background: Cardiovascular disease (CVD) remains a leading cause of morbidity and
mortality worldwide. Polypills, containing various combinations of medications for primary …

As the global population ages and cardiovascular risk factors rise, we can expect a
continued increase in atherosclerotic disease. Low-density lipoprotein cholesterol (LDL-C) …

People who have had a stroke are confronted with multiple medications and complex
treatment regimens, both associated with low adherence. As a result of barriers at the health …

There are stark inequities in stroke incidence, prevalence, care, and outcomes. This issue of
Stroke features manuscripts from the third annual HEADS-UP (Health Equity and Actionable …

During patient follow-up in a randomized trial, some deaths may occur. Where death (or
noncardiovascular death) is not part of an outcome of interest it is termed a competing risk …

Objective Adherence to anti-platelet medications is critical following coronary stenting, but
prior studies indicate that clinician assessment and patient self-assessment of adherence …

Background: Evidence-based International clinical practice guidelines, universally
recommend secondary prevention medications for those with previous cardiovascular …

The issue of suboptimal drug regimen adherence in secondary cardiovascular prevention
presents a significant barrier to improving patient outcomes. To address this, the utilization of …

COVID-19 has had a negative impact on the health care of patients with cardiovascular
disease and patients at high risk of cardiovascular disease. The restrictions affecting access …